Episode 43: First Systematic Review of Placebo Response in CLE Trials

When designing a trial for cutaneous lupus erythematosus (CLE), consider earlier primary endpoints, limited background therapy, and balanced racial representation to address placebo response. That’s just a few of the insights from the first-ever systematic review of placebo response in CLE trials, shared here by Dr. Stéphanie Légaré, first author of Placebo Response in Randomised Controlled Trials of Systemic Therapies for Cutaneous Lupus Erythematosus: A Systematic Review and Meta-Analysis. Want more on placebo response in rheumatology trials? Learn from leading KOLs Drs. Andreas Kerschbaumer and Joan Merrill at a free educational breakfast event happening during ACR Convergence 2026. Register here: https://go.inderocro.com/podcast/desc....